Altered Cellular Metabolism Is a Consequence of Loss of the Ataxia-Linked Protein Sacsin
Mitochondrial dysfunction is implicated in the pathogenesis of the neurological condition autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), yet precisely how the mitochondrial metabolism is affected is unknown. Thus, to better understand changes in the mitochondrial metabolism caused by loss of the sacsin protein (encoded by the SACS gene, which is mutated in ARSACS), we performed mass spectrometry-based tracer analysis, with both glucose- and glutamine-traced carbon. Comparing the metabolite profiles between wild-type and sacsin-knockout cell lines revealed increased reliance on aerobic glycolysis in sacsin-deficient cells, as evidenced by the increase in lactate and reduction of glucose. Moreover, sacsin knockout cells differentiated towards a neuronal phenotype had increased levels of tricarboxylic acid cycle metabolites relative to the controls. We also observed disruption in the glutaminolysis pathway in differentiated and undifferentiated cells in the absence of sacsin. In conclusion, this work demonstrates consequences for cellular metabolism associated with a loss of sacsin, which may be relevant to ARSACS.
Authors
- Gábor Czibik (ORCID: https://orcid.org/0000-0002-4914-6794)
- Katiuscia Bianchi (ORCID: https://orcid.org/0000-0002-4549-4476)
- Laura Perna
- Valle Morales (ORCID: https://orcid.org/0000-0003-0856-5121)
- Grace Salsbury (ORCID: https://orcid.org/0000-0002-6607-4083)
- J. Paul Chapple (ORCID: https://orcid.org/0000-0003-1876-1505)
- Chris Smith (ORCID: https://orcid.org/0000-0003-1808-6570)
- Mohammed Dushti
Institutions
- Queen Mary University of London (GB)
- Kuwait University (KW)
- William Harvey Research Institute (GB)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2024-12-10
- DOI
- https://doi.org/10.3390/ijms252413242
- Citations
- 1
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.27
Funders
- Biotechnology and Biological Sciences Research Council